Nexien Biopharma, Inc. (NXEN) SEC Filing 10-K Annual Report for the fiscal year ending Thursday, June 30, 2022

Nexien Biopharma, Inc.

CIK: 1625288 Ticker: NXEN
Cover - USD ($)
12 Months Ended
Jun. 30, 2022
Sep. 26, 2022
Dec. 31, 2021
Cover [Abstract]   
Document Type10-K  
Amendment Flagfalse  
Document Annual Reporttrue  
Document Transition Reportfalse  
Document Period End DateJun. 30, 2022  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2022  
Current Fiscal Year End Date--06-30  
Entity File Number000-55320  
Entity Registrant NameNEXIENBIOPHARMA, INC.  
Entity Central Index Key0001625288  
Entity Tax Identification Number26-2049376  
Entity Incorporation, State or Country CodeDE  
Entity Address, Address Line One4340 East Kentucky Avenue  
Entity Address, Address Line TwoSuite 206  
Entity Address, City or TownGlendale  
Entity Address, State or ProvinceCO  
Entity Address, Postal Zip Code80246  
City Area Code303  
Local Phone Number495-7583  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companytrue  
Elected Not To Use the Extended Transition Periodfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 1,702,974
Entity Common Stock, Shares Outstanding 61,272,196 
Documents Incorporated by ReferenceNone  
ICFR Auditor Attestation Flagfalse  
Auditor Firm ID2738  
Auditor NameM&K CPAS, PLLC  
Auditor LocationHouston, TX  

View differences made from one year to another to evaluate Nexien Biopharma, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nexien Biopharma, Inc..


Assess how Nexien Biopharma, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nexien Biopharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Material Contracts, Statements, Certifications & more

Nexien Biopharma, Inc. provided additional information to their SEC Filing as exhibits

Ticker: NXEN
CIK: 1625288
Form Type: 10-K Annual Report
Accession Number: 0001493152-22-026974
Submitted to the SEC: Wed Sep 28 2022 11:26:26 AM EST
Accepted by the SEC: Wed Sep 28 2022
Period: Thursday, June 30, 2022
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: